Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Green, Elaine
DOB:	05-AUG-1942 (Age: 83)
Gender:	female
Address:	Studio 30N Maurice lakes M1 East Georginastad (United Kingdom)
ID:	9467-500577-4 (ECI)

Report
Date:	23-OCT-2015

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Cornbrook Medical Practice City Road 204 M3 3 Manchester (United Kingdom)

Specimen
Collected:	23-OCT-2015

Chemistry

Test	23-OCT-2015	Reference Range	Unit
Glucose [Mass/volume] in Blood	88.8	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	17.2	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	3.3 H	0.6 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	8.8	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	139.5	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	3.9	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	103.9	98 - 107	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	23.3	22 - 29	mmol/L
Protein [Mass/volume] in Serum or Plasma	7.6	6.6 - 8.3	g/dL
Albumin [Mass/volume] in Serum or Plasma	4.7	3.5 - 5.0	g/dL
Globulin [Mass/volume] in Serum by calculation	2.1 L	20 - 39	g/L
Bilirubin.total [Mass/volume] in Serum or Plasma	0.5	0.1 - 1.2	mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma	133.8 H	30 - 120	U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma	37.8	10 - 40	U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma	35.1	10 - 40	U/L
Cholesterol [Mass/volume] in Serum or Plasma	184.5	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	194.3 H	0 - 149	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	117.9 H	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	51.5	40 - 90	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows significantly elevated creatinine, suggesting impaired renal function, and increased alkaline phosphatase, which may indicate hepatobiliary or bone involvement. Lipid profile reveals high triglycerides and LDL cholesterol, increasing cardiovascular risk. Globulin is markedly low, possibly reflecting immunodeficiency or protein loss. Other parameters are within normal limits. Further clinical correlation and follow-up are recommended.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows significantly elevated creatinine, suggesting impaired renal function, and increased alkaline phosphatase, which may indicate hepatobiliary or bone involvement. Lipid profile reveals high triglycerides and LDL cholesterol, increasing cardiovascular risk. Globulin is markedly low, possibly reflecting immunodeficiency or protein loss. Other parameters are within normal limits. Further clinical correlation and follow-up are recommended.